Basic information Uses Safety Supplier Related

Ethyl 4-methyl-5-thiazoleactate

Basic information Uses Safety Supplier Related

Ethyl 4-methyl-5-thiazoleactate Basic information

Product Name:
Ethyl 4-methyl-5-thiazoleactate
Synonyms:
  • ETHYL 4-METHYLTHIAZOLE-5-CARBOXYLATE
  • ETHYL 4-METHYL-5-THIAZOLEACTATE
  • ETHYL 4-METHYL-5-THIAZOLYL FORMATE
  • 5-THIAZOLECARBOXYLIC ACID, 4-METHYL-, ETHYL ESTER
  • Ethyl-4-methyl-5-thizaolecarboxylate
  • 4-Methyl-5-Thiazolecarboxylic Acid Ethyl Ester
  • ETHYL 4-METHYL-5-THIAZOLECARBOXYLATE
  • ethyl 4-methyl-1,3-thiazole-5-carboxylate
CAS:
20582-55-2
MF:
C7H9NO2S
MW:
171.22
Product Categories:
  • Febuxostat
Mol File:
20582-55-2.mol
More
Less

Ethyl 4-methyl-5-thiazoleactate Chemical Properties

Melting point:
28°C(lit.)
Boiling point:
233°C(lit.)
Density 
1.198±0.06 g/cm3(Predicted)
storage temp. 
Keep in dark place,Sealed in dry,Room Temperature
form 
powder to lump
pka
1.57±0.10(Predicted)
color 
White to Almost white
LogP
1.410 (est)
CAS DataBase Reference
20582-55-2(CAS DataBase Reference)
More
Less

Safety Information

HazardClass 
IRRITANT
HS Code 
2934208090
More
Less

Ethyl 4-methyl-5-thiazoleactate Usage And Synthesis

Uses

Ethyl 4-methylthiazolium-5-carboxylate is a key intermediate in the synthesis of cefditorenpivoxil. Cefditorenpivoxil was developed by Meiji Seika Co., Ltd. of Japan and launched in Japan in 1994 under the trade name Meiact. Cefditorenpivoxil has a broad antibacterial spectrum against both Gram-positive and Gram-negative bacteria.

Chemical Properties

white to light yellow crystal powde

Synthesis

7210-76-6

20582-55-2

General procedure for the synthesis of ethyl 4-methylthiazole-5-carboxylate from ethyl 2-amino-4-methylthiazole-5-carboxylate: compound 3a (4.0 g, 21.5 mmol) was dissolved in 106 mL of 30% hypophosphite (H3PO2) solution. The reaction system was cooled to -5°C, after which sodium nitrite (NaNO2, 3.0 g, 2.0 eq.) was dissolved in 12 mL of water and slowly added dropwise to the reaction solution. After the dropwise addition, the reaction mixture was transferred to 0°C and kept for 1 hour, then stirring was continued for 2 hours at room temperature. Subsequently, pre-cooled sodium hydroxide solution (17 g NaOH dissolved in 200 mL of water) was added slowly dropwise. The reaction mixture was adjusted to neutral with sodium bicarbonate (NaHCO3) solution and then extracted with ether (Et2O, 50 mL x 3). The organic phases were combined and purified by column chromatography (eluent ratio: petroleum ether:ethyl acetate = 50:1, v/v) to give the yellow semi-solid product 3b (2.1 g, 56% yield).

References

[1] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 23, p. 6231 - 6235
[2] Patent: CN101921268, 2016, B. Location in patent: Paragraph 0128; 0131; 0136-0139
[3] Tetrahedron, 2013, vol. 69, # 22, p. 4436 - 4444

Ethyl 4-methyl-5-thiazoleactateSupplier

Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Alfa Aesar
Tel
400-6106006
Email
saleschina@alfa-asia.com
Wuhan Chemwish Technology Co., Ltd
Tel
86-027-67849912
Email
sales@chemwish.com
Capot Chemical Co., Ltd
Tel
+86 (0) 571 85 58 67 18